LCN2 and hepatocellular carcinoma: We finally evaluated the performance of the CCL20/LCN2-based model (model_2) in discriminating HCC from the comprehensive control that includes all nontumor subjects and the control of patients with liver cirrhosis, which constitutes the highest risk group for the development of HCC.